Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Nevirapine XR vs Viramune in HIV-1
NCT02194179Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of nevirapine in human immunodeficiency virus type 1 infection (HIV-1) (9 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area Under the Concentration-Time Curve at Steady State at Day 22, Minimum Plasma Concentration at Steady State at Day 22 and 1 more. Started Dec 2006; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02194179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194179.